Patent · US Active

Somatostatin receptor antagonists and glucose control or hypoglycemia

US8206722B2 · kind B2 · utility

1Cited by

5References

16Claims

0Family size

Assignee

The Governing Council of the University of Toronto · CA

Inventors

Mladen Vranic · Toronto, CA
Jessica Yue · Markham, CA
Suad Efendic · Lidingö, SE

Key dates

Filing date	Nov 9, 2010
Grant date	Jun 26, 2012
Priority date	—
Expiry date	Nov 9, 2030

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2310/11
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present disclosure provides methods and uses for controlling tight blood glucose levels in a subject comprising administering an effective amount of a somatostatin inhibitor. The present disclosure provides methods and uses for treating or preventing hypoglycemia in a subject comprising administering an effective amount of a somatostatin inhibitor.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.